$33.60

+0.16 (+0.48%)

Weekly Expected Move ±3.7%

$31 $32 $34 $35 $36

NASDAQ · Healthcare · Medical - Healthcare Information Services · Tech Score Neutral · Power 49 · $1.5B mcap · 44M float · 1.58% daily turnover · Short 65% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE

46.1 / 100

NoneWeakNarrowWide

Primary source: Cost Advantage · ROIC: 3.2% · 5Y Avg: 1.3%

Cost Advantage ★

Intangibles

Switching Cost

Network Effect

Scale

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. OMCL shows a Weak competitive edge (46.1/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 3.2% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$50

Low

$58

Avg Target

$65

High

Based on 2 analysts since Jul 30, 2026 earnings

Analyst Recommendations

Strong Buy: 0Buy: 9Hold: 10Sell: 0Strong Sell: 0

Rating Summary

ConsensusHold

Avg Target$57.50

Analysts2

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-07-31	KeyBanc	—	$70	$65	-5	+75.2%	$37.11
2026-07-31	Wells Fargo	Stan Berenshteyn	$52	$50	-2	+34.7%	$37.11
2026-04-29	Craig-Hallum	—	Initiated	$55	—	+23.7%	$44.45
2026-04-28	KeyBanc	—	$60	$70	+10	+58.0%	$44.31
2026-03-13	UBS	—	$53	$60	+7	+70.9%	$35.10
2026-02-06	Piper Sandler	—	$55	$49	-6	+25.4%	$39.08
2026-01-16	UBS	—	Initiated	$53	—	+4.0%	$50.98
2026-01-07	KeyBanc	—	Initiated	$60	—	+26.4%	$47.45
2026-01-05	Wells Fargo	—	$35	$52	+17	+13.9%	$45.64
2025-08-11	Piper Sandler	Jessica Tassan	$61	$55	-6	+76.8%	$31.11
2025-05-14	Wells Fargo	Stan Berenshteyn	$40	$35	-5	+27.5%	$27.46
2025-01-13	Wells Fargo	Stan Berenshteyn	$158	$40	-118	-7.8%	$43.37
2024-10-31	Barclays	Stephanie Davis	$39	$58	+19	+9.3%	$53.05
2024-08-05	Piper Sandler	Sean Wieland	$150	$61	-89	+52.5%	$40.00
2024-08-01	Barclays	Stephanie Davis	Initiated	$39	—	-0.6%	$39.22
2022-11-18	J.P. Morgan	—	Initiated	$57	—	+6.3%	$53.63
2022-08-08	Piper Sandler	Jessica Tassan	$162	$150	-12	+37.5%	$109.12
2022-06-16	Wells Fargo	Stan Berenshteyn	Initiated	$158	—	+43.9%	$109.82
2022-05-03	Piper Sandler	—	Initiated	$162	—	+41.0%	$114.90

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+

Oct 02, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. OMCL receives an overall rating of B+. Strongest factors: DCF (5/5), ROA (4/5), P/B (4/5). Areas of concern: ROE (2/5), D/E (2/5), P/E (1/5).

Rating Change History

Date	From	To
2026-08-24	A-	B+
2026-08-18	B+	A-
2026-08-17	A-	B+
2026-08-14	B+	A-
2026-07-27	B	B+
2026-07-01	B+	B
2026-06-30	B	B+
2026-06-25	B+	B
2026-06-24	A-	B+
2026-06-23	B+	A-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 62 Grade A

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. OMCL scores highest in Momentum (90/100) and lowest in Profitability (31/100). An overall grade of A places OMCL among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

2.82

Grey Zone

Piotroski F-Score

9/9

✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓

Beneish M-Score

-2.89

Unlikely Manipulator

Ohlson O-Score

-8.72

Bankruptcy prob: 0.0%

Low Risk

Credit Rating

AA-

Score: 83.1/100

Trend: Improving

Earnings Quality

75/100

OCF/NI: 4.67x

Accruals: -6.9%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. OMCL scores 2.82, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. OMCL scores 9/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. OMCL's score of -2.89 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. OMCL's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. OMCL receives an estimated rating of AA- (score: 83.1/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). OMCL's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

39.30x

PEG

0.56x

P/S

1.23x

P/B

1.18x

P/FCF

13.55x

P/OCF

10.49x

EV/EBITDA

17.18x

EV/Revenue

1.45x

EV/EBIT

28.22x

EV/FCF

12.79x

Earnings Yield

2.04%

FCF Yield

7.38%

Shareholder Yield

3.25%

Graham Number

$23.10

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 39.3x earnings, OMCL commands a growth premium. Graham's intrinsic value formula yields $23.10 per share, 45% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

0.639

NI / EBT

Interest Burden

0.954

EBT / EBIT

EBIT Margin

0.051

EBIT / Rev

Asset Turnover

0.602

Rev / Assets

Equity Multiplier

1.622

Assets / Equity

ROE

3.1%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. OMCL's ROE of 3.1% is driven by Asset Turnover (0.602), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate

15.00%

Fair P/E

38.50x

Intrinsic Value

$32.62

Price/Value

1.27x

Margin of Safety

-27.29%

Premium

27.29%

Assessment

Neutral

Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with OMCL's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. OMCL trades at a 27% premium to its adjusted intrinsic value of $32.62, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 39.3x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$33.60

Median 1Y

$27.13

5th Pctile

$12.31

95th Pctile

$59.74

Ann. Volatility

48.1%

Analyst Target

$57.50

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
Randall A. Lipps Chairman, President and Chief Executive Officer	$846,891	$5,219,576	$7,531,852
Nnamdi T. Njoku Executive Vice President, Chief Operating Officer	$645,000	$2,456,275	$4,005,114
Corey J. Manley Executive Vice President, Chief Legal and Administrative Officer	$416,623	$1,473,739	$2,456,010
Nchacha E. Etta Former Executive Vice President, Chief Financial Officer	$449,423	$—	$1,985,158
H. Baird Radford, III Executive Vice President, Chief Financial Officer	$159,519	$1,156,572	$1,513,514

CEO Pay Ratio

66:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $7,531,852

Avg Employee Cost (SGA/emp): $114,416

Employees: 3,580

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

3,580

-2.5% YoY

Revenue / Employee

$330,962

Rev: $1,184,845,000

Profit / Employee

$573

NI: $2,052,000

SGA / Employee

$114,416

Avg labor cost proxy

R&D / Employee

$24,769

Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
ROE	7.9%	7.4%	6.9%	5.6%	4.3%	0.5%	-1.6%	-2.1%	-3.0%	-1.8%	-1.8%	-1.8%	-1.5%	1.0%	1.7%	1.9%	1.6%	0.2%	1.6%	3.1%	3.06%
ROA	4.3%	3.9%	3.6%	3.0%	2.3%	0.3%	-0.8%	-1.1%	-1.6%	-0.9%	-0.9%	-0.9%	-0.8%	0.6%	1.0%	1.0%	0.9%	0.1%	1.0%	1.9%	1.89%
ROIC	9.3%	7.9%	6.6%	5.3%	3.9%	-0.1%	-1.7%	-2.0%	-2.9%	-2.1%	-1.9%	-2.2%	-2.0%	0.2%	0.6%	0.9%	0.9%	0.1%	1.6%	3.2%	3.18%
ROCE	5.7%	7.1%	6.4%	3.3%	2.6%	-0.1%	-1.7%	-1.9%	-2.7%	-1.9%	-1.5%	-1.8%	-1.8%	1.6%	1.9%	2.3%	2.3%	0.9%	2.8%	4.1%	4.13%
Gross Margin	49.5%	48.0%	47.1%	47.7%	45.7%	40.9%	43.0%	45.0%	44.2%	40.7%	38.7%	41.3%	43.5%	46.6%	41.1%	43.9%	43.3%	41.5%	45.3%	49.0%	48.98%
Operating Margin	9.9%	3.7%	1.6%	3.8%	5.3%	-12.9%	-7.9%	2.6%	1.2%	-9.0%	-7.6%	1.2%	2.5%	4.5%	-4.3%	2.8%	2.7%	0.5%	5.4%	10.4%	10.39%
Net Margin	9.9%	4.5%	2.6%	2.7%	4.8%	-9.5%	-5.2%	1.2%	1.9%	-5.6%	-6.4%	1.3%	3.1%	5.2%	-2.6%	1.9%	1.8%	-0.6%	3.7%	7.8%	7.78%
EBITDA Margin	17.1%	11.1%	9.3%	11.4%	12.4%	-4.6%	0.4%	10.6%	9.1%	0.2%	2.6%	9.4%	12.2%	15.3%	3.8%	10.3%	9.8%	8.1%	11.4%	4.4%	4.43%
FCF Margin	21.0%	17.9%	9.9%	2.7%	0.5%	2.0%	4.8%	11.4%	15.1%	11.9%	15.5%	14.4%	11.1%	12.5%	10.3%	8.9%	9.5%	7.1%	9.1%	11.3%	11.34%
OCF Margin	23.2%	20.5%	13.2%	6.1%	4.2%	6.0%	8.4%	15.3%	19.0%	15.8%	19.8%	18.9%	16.0%	16.9%	14.4%	12.9%	13.0%	10.7%	12.7%	14.7%	14.65%
ROE 3Y Avg	snapshot only																				1.04%
ROE 5Y Avg	snapshot only																				1.34%
ROA 3Y Avg	snapshot only																				0.71%
ROIC 3Y Avg	snapshot only																				1.12%
ROIC Economic	snapshot only																				2.57%
Cash ROA	snapshot only																				9.14%
Cash ROIC	snapshot only																				15.42%
CROIC	snapshot only																				11.94%
NOPAT Margin	snapshot only																				3.02%
Pretax Margin	snapshot only																				4.90%
R&D / Revenue	snapshot only																				7.09%
SGA / Revenue	snapshot only																				32.95%
SBC / Revenue	snapshot only																				2.64%

Valuation

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
P/E Ratio	89.42	115.54	86.26	86.86	83.01	398.84	-149.93	-144.50	-59.69	-84.04	-63.51	-60.02	-114.45	164.33	76.90	59.46	71.32	992.52	75.05	49.01	39.303
P/S Ratio	6.70	7.95	5.18	4.18	3.05	1.74	2.08	2.71	1.73	1.49	1.21	1.15	1.90	1.85	1.43	1.19	1.21	1.72	1.25	1.54	1.226
P/B Ratio	6.46	7.84	5.77	4.82	3.51	1.99	2.30	2.88	1.73	1.44	1.12	1.04	1.64	1.66	1.30	1.09	1.16	1.65	1.22	1.48	1.183
P/FCF	31.87	44.34	52.06	153.76	616.14	85.35	43.63	23.79	11.49	12.56	7.80	8.03	17.12	14.77	13.98	13.41	12.75	24.12	13.72	13.55	13.545
P/OCF	28.86	38.80	39.17	68.27	72.16	28.96	24.72	17.72	9.13	9.45	6.12	6.11	11.92	10.97	9.95	9.29	9.27	16.00	9.84	10.49	10.485
EV/EBITDA	40.10	52.60	39.92	36.88	29.80	26.10	42.24	56.84	47.38	30.58	21.64	21.46	30.57	18.11	13.75	11.07	12.18	21.25	12.20	17.18	17.177
EV/Revenue	6.75	8.11	5.46	4.47	3.30	1.95	2.29	2.88	1.86	1.62	1.29	1.20	1.93	1.85	1.42	1.17	1.22	1.73	1.21	1.45	1.450
EV/EBIT	73.57	102.52	87.25	96.07	90.86	-1088.06	-95.39	-101.23	-44.27	-53.39	-50.05	-39.09	-85.66	85.81	55.54	37.05	41.32	150.12	35.17	28.22	28.216
EV/FCF	32.06	45.24	54.89	164.37	668.57	95.77	48.00	25.24	12.35	13.63	8.34	8.33	17.39	14.78	13.86	13.14	12.87	24.21	13.26	12.79	12.789
Earnings Yield	1.1%	0.9%	1.2%	1.2%	1.2%	0.3%	-0.7%	-0.7%	-1.7%	-1.2%	-1.6%	-1.7%	-0.9%	0.6%	1.3%	1.7%	1.4%	0.1%	1.3%	2.0%	2.04%
FCF Yield	3.1%	2.3%	1.9%	0.7%	0.2%	1.2%	2.3%	4.2%	8.7%	8.0%	12.8%	12.5%	5.8%	6.8%	7.2%	7.5%	7.8%	4.1%	7.3%	7.4%	7.38%
PEG Ratio	snapshot only																				0.561
Price/Tangible Book	snapshot only																				5.606
EV/OCF	snapshot only																				9.899
EV/Gross Profit	snapshot only																				3.240
Acquirers Multiple	snapshot only																				30.670
Shareholder Yield	snapshot only																				3.25%
Graham Number	snapshot only																				$23.10

Leverage & Solvency

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Current Ratio	2.62	0.89	0.82	2.11	2.25	2.06	2.06	2.38	2.47	2.52	2.38	2.45	1.05	1.37	1.38	1.42	1.44	1.43	1.50	1.64	1.644
Quick Ratio	2.32	0.75	0.67	1.71	1.86	1.71	1.75	2.03	2.16	2.22	2.13	2.22	0.95	1.22	1.23	1.24	1.21	1.22	1.29	1.43	1.427
Debt/Equity	0.48	0.47	0.57	0.57	0.54	0.55	0.54	0.53	0.52	0.52	0.52	0.51	0.50	0.31	0.31	0.30	0.17	0.17	0.16	0.15	0.155
Net Debt/Equity	0.04	0.16	0.31	0.33	0.30	0.24	0.23	0.18	0.13	0.12	0.08	0.04	0.03	0.00	-0.01	-0.02	0.01	0.01	-0.04	-0.08	-0.083
Debt/Assets	0.26	0.25	0.29	0.29	0.28	0.28	0.27	0.28	0.28	0.28	0.27	0.27	0.27	0.18	0.18	0.18	0.11	0.10	0.10	0.10	0.100
Debt/EBITDA	2.98	3.10	3.74	4.07	4.26	6.37	8.97	9.83	13.14	10.11	9.33	10.22	9.13	3.36	3.28	3.16	1.76	2.12	1.66	1.90	1.900
Net Debt/EBITDA	0.25	1.04	2.06	2.38	2.34	2.84	3.84	3.26	3.30	2.40	1.38	0.77	0.47	0.01	-0.12	-0.22	0.11	0.08	-0.42	-1.02	-1.017
Interest Coverage	15.48	15.73	12.92	10.09	6.87	-1.87	-26.95	-31.15	—	—	-25.12	-14.54	-7.03	5.31	7.79	12.32	10.62	2.68	7.71	12.52	12.525
Equity Multiplier	1.85	1.87	1.97	1.95	1.92	1.96	1.97	1.89	1.87	1.87	1.92	1.91	1.87	1.71	1.71	1.70	1.60	1.60	1.59	1.55	1.548
Cash Ratio	snapshot only																				0.686
Debt Service Coverage	snapshot only																				20.573
Cash to Debt	snapshot only																				1.535
FCF to Debt	snapshot only																				0.707
Defensive Interval	snapshot only																				390.5 days

Efficiency & Turnover

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Asset Turnover	0.57	0.57	0.60	0.61	0.62	0.60	0.58	0.57	0.54	0.52	0.49	0.48	0.47	0.51	0.51	0.52	0.55	0.58	0.59	0.60	0.602
Inventory Turnover	5.22	5.34	5.29	5.19	5.51	5.29	5.06	4.95	5.11	5.05	5.20	5.66	5.93	6.41	6.62	6.48	6.54	7.19	7.27	6.80	6.801
Receivables Turnover	5.07	5.25	4.83	4.83	4.45	4.80	4.14	4.23	3.78	4.16	3.86	4.20	4.06	4.38	4.54	4.85	4.73	5.01	4.89	5.42	5.424
Payables Turnover	9.68	10.33	10.07	10.49	9.35	10.48	10.42	12.03	10.90	12.00	11.93	13.07	12.82	13.15	13.37	11.50	12.00	14.23	12.40	12.27	12.275
DSO	72	69	76	76	82	76	88	86	96	88	94	87	90	83	80	75	77	73	75	67	67.3 days
DIO	70	68	69	70	66	69	72	74	71	72	70	64	62	57	55	56	56	51	50	54	53.7 days
DPO	38	35	36	35	39	35	35	30	33	30	31	28	28	28	27	32	30	26	29	30	29.7 days
Cash Conversion Cycle	104	102	108	111	109	110	125	130	134	130	134	124	123	113	108	100	103	98	95	91	91.2 days
Fixed Asset Turnover	snapshot only																				8.688
Operating Cycle	snapshot only																				121.0 days
Cash Velocity	snapshot only																				4.061
Capital Intensity	snapshot only																				1.603

Growth (YoY)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue	20.1%	26.9%	31.1%	27.4%	22.3%	14.5%	5.7%	-1.8%	-9.4%	-11.5%	-13.0%	-12.5%	-10.3%	-3.0%	3.0%	6.4%	10.7%	6.5%	7.9%	8.5%	8.45%
Net Income	1.1%	1.4%	1.1%	1.4%	-40.1%	-92.7%	-1.2%	-1.4%	-1.7%	-4.6%	-19.8%	10.4%	48.6%	1.6%	2.0%	2.1%	2.1%	-83.6%	-3.5%	69.3%	69.28%
EPS	91.3%	1.1%	98.8%	3.3%	-36.8%	-91.9%	-1.3%	-1.4%	-1.7%	-4.5%	-17.6%	11.5%	49.5%	1.6%	2.0%	2.1%	2.1%	-83.2%	-2.2%	71.3%	71.34%
FCF	1.4%	38.4%	-36.4%	-84.1%	-97.1%	-87.0%	-49.4%	3.1%	26.6%	4.2%	1.8%	10.2%	-33.9%	2.3%	-32.0%	-34.0%	-5.7%	-39.4%	-4.1%	38.1%	38.12%
EBITDA	70.2%	62.8%	38.5%	-3.0%	-19.3%	-44.5%	-58.1%	-59.0%	-67.9%	-37.3%	-3.8%	-3.7%	44.4%	87.2%	78.1%	1.0%	75.0%	-15.4%	3.4%	-13.4%	-13.36%
Op. Income	1.6%	1.5%	74.4%	-25.8%	-51.5%	-1.0%	-1.4%	-1.6%	-2.0%	-14.0%	-0.7%	-0.0%	36.5%	1.2%	1.4%	1.5%	1.6%	12.2%	1.8%	2.4%	2.38%
OCF Growth	snapshot only																				23.63%
Asset Growth	snapshot only																				-6.83%
Equity Growth	snapshot only																				2.21%
Debt Growth	snapshot only																				-47.97%
Shares Change	snapshot only																				-1.20%

Growth (CAGR)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue 3Y	11.4%	12.9%	14.1%	14.6%	15.0%	13.0%	11.1%	10.9%	10.0%	8.7%	6.4%	3.0%	-0.2%	-0.6%	-1.8%	-3.0%	-3.5%	-2.9%	-1.1%	0.3%	0.31%
Revenue 5Y	10.5%	10.3%	12.3%	13.1%	13.7%	12.6%	11.1%	10.3%	8.9%	7.8%	6.4%	5.3%	4.3%	4.4%	4.2%	4.9%	5.7%	5.8%	6.0%	4.8%	4.77%
EPS 3Y	12.8%	19.7%	18.3%	5.7%	-5.8%	-55.3%	—	—	—	—	—	—	—	-44.2%	-32.8%	-27.7%	-25.9%	-28.8%	—	—	—
EPS 5Y	50.0%	1.5%	—	—	—	-25.8%	—	—	—	—	—	—	—	-28.2%	-22.2%	-15.5%	-13.2%	-42.6%	-10.0%	-7.7%	-7.75%
Net Income 3Y	19.3%	27.3%	23.4%	8.3%	-3.8%	-54.8%	—	—	—	—	—	—	—	-45.6%	-33.5%	-27.5%	-25.4%	-28.6%	—	—	—
Net Income 5Y	58.2%	1.6%	—	—	—	-23.9%	—	—	—	—	—	—	—	-27.2%	-21.1%	-14.0%	-12.1%	-42.3%	-10.2%	-8.1%	-8.13%
EBITDA 3Y	25.3%	28.0%	18.6%	10.5%	5.4%	-12.1%	-21.8%	-19.3%	-23.9%	-17.2%	-17.7%	-27.4%	-28.0%	-13.3%	-10.5%	-7.3%	-6.7%	-0.2%	21.0%	19.0%	18.97%
EBITDA 5Y	20.9%	21.9%	30.2%	29.5%	26.6%	10.4%	-2.2%	-5.7%	-12.6%	-6.1%	-7.7%	-11.8%	-11.5%	-4.4%	-3.9%	0.4%	2.2%	-2.1%	0.5%	-7.7%	-7.72%
Gross Profit 3Y	13.1%	14.2%	14.6%	14.5%	14.1%	10.5%	7.9%	8.0%	7.5%	6.3%	3.1%	-2.3%	-6.1%	-5.0%	-5.5%	-5.8%	-5.8%	-5.1%	-1.9%	1.1%	1.09%
Gross Profit 5Y	11.7%	12.1%	14.3%	15.2%	15.4%	12.8%	10.6%	9.0%	7.0%	5.9%	3.8%	2.1%	1.1%	1.7%	1.8%	3.3%	4.5%	4.0%	4.6%	3.1%	3.10%
Op. Income 3Y	33.6%	26.3%	9.9%	-4.8%	-14.1%	—	—	—	—	—	—	—	—	-60.6%	-44.9%	-33.2%	-27.0%	—	—	—	—
Op. Income 5Y	39.4%	69.1%	—	—	—	—	—	—	—	—	—	—	—	-41.2%	-30.6%	-19.6%	-13.2%	-29.6%	-4.2%	-5.7%	-5.66%
FCF 3Y	2.0%	59.9%	29.3%	-16.5%	-59.6%	-31.8%	-10.8%	8.4%	23.2%	-2.4%	-2.9%	-10.4%	-19.3%	-11.8%	-0.7%	44.1%	1.6%	47.4%	22.8%	0.1%	0.14%
FCF 5Y	53.8%	61.0%	34.8%	-4.1%	-17.7%	—	—	—	84.6%	22.4%	25.5%	21.4%	3.8%	10.8%	6.5%	-1.5%	3.1%	-10.4%	-9.8%	-8.1%	-8.10%
OCF 3Y	60.0%	30.6%	12.4%	-13.0%	-29.5%	-18.7%	-9.5%	4.8%	15.9%	-0.9%	0.0%	-5.6%	-11.9%	-6.8%	1.1%	24.2%	40.5%	17.8%	13.5%	-1.1%	-1.13%
OCF 5Y	36.6%	37.1%	23.9%	1.7%	4.6%	25.7%	47.0%	48.0%	29.9%	11.7%	14.4%	11.8%	1.5%	5.3%	2.6%	-2.1%	1.2%	-7.3%	-6.5%	-5.5%	-5.50%
Assets 3Y	24.9%	25.6%	21.7%	21.2%	20.5%	21.2%	22.3%	21.5%	8.9%	6.9%	6.6%	5.3%	3.9%	-0.3%	0.5%	0.2%	-3.7%	-3.7%	-3.8%	-3.1%	-3.06%
Assets 5Y	17.1%	18.0%	18.5%	18.6%	18.7%	17.7%	16.7%	16.4%	16.1%	15.5%	14.2%	13.9%	13.1%	11.3%	11.8%	11.9%	2.5%	1.6%	1.2%	0.4%	0.38%
Equity 3Y	21.5%	19.0%	13.7%	12.2%	12.0%	10.2%	9.2%	9.4%	8.9%	7.1%	5.5%	4.5%	3.5%	2.7%	5.4%	5.0%	2.4%	2.9%	3.2%	3.5%	3.54%
Book Value 3Y	14.9%	12.0%	9.1%	9.5%	9.7%	9.0%	8.1%	7.1%	7.4%	5.9%	6.0%	5.4%	4.9%	5.3%	6.4%	4.6%	1.8%	2.7%	2.4%	3.0%	3.05%
Dividend 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Growth Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue Stability	0.94	0.86	0.87	0.90	0.90	0.91	0.90	0.91	0.83	0.76	0.65	0.52	0.35	0.37	0.28	0.24	0.22	0.31	0.44	0.49	0.488
Earnings Stability	0.73	0.73	0.62	0.70	0.44	0.00	0.11	0.22	0.28	0.38	0.47	0.56	0.53	0.48	0.43	0.40	0.34	0.35	0.12	0.09	0.092
Margin Stability	0.97	0.97	0.96	0.96	0.95	0.96	0.96	0.96	0.95	0.95	0.94	0.93	0.92	0.94	0.93	0.94	0.95	0.96	0.96	0.94	0.942
Rev. Growth Consistency	1.00	0.50	0.50	1.00	1.00	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.00	1.000
Earn. Growth Consistency	0.50	0.50	0.50	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.00	0.00	0.00	1.00	1.000
FCF Positive Streak	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Earnings Persistence	0.50	0.50	0.50	0.99	0.84	0.50	0.20	0.20	0.20	0.20	0.50	0.50	0.50	0.20	0.20	0.20	0.20	0.50	0.50	0.50	0.500
Earnings Smoothness	0.28	0.17	0.31	0.99	0.50	0.00	—	—	—	—	—	—	—	—	—	—	—	0.00	0.96	0.49	0.485
ROE Trend	0.02	0.01	0.01	-0.00	-0.01	-0.05	-0.07	-0.08	-0.09	-0.05	-0.04	-0.04	-0.02	0.02	0.03	0.04	0.04	0.01	0.02	0.03	0.030
Gross Margin Trend	0.02	0.01	0.01	0.00	-0.01	-0.02	-0.03	-0.05	-0.05	-0.04	-0.04	-0.05	-0.04	-0.02	-0.00	0.01	0.02	-0.01	0.01	0.02	0.021
FCF Margin Trend	0.10	0.05	-0.05	-0.14	-0.15	-0.15	-0.10	-0.01	0.04	0.02	0.08	0.07	0.03	0.06	0.00	-0.04	-0.04	-0.05	-0.04	-0.00	-0.003
Sustainable Growth Rate	7.9%	7.4%	6.9%	5.6%	4.3%	0.5%	—	—	—	—	—	—	—	1.0%	1.7%	1.9%	1.6%	0.2%	1.6%	3.1%	3.06%
Internal Growth Rate	4.4%	4.1%	3.7%	3.1%	2.3%	0.3%	—	—	—	—	—	—	—	0.6%	1.0%	1.1%	0.9%	0.1%	1.0%	1.9%	1.92%

Cash Flow Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
OCF/Net Income	3.10	2.98	2.20	1.27	1.15	13.77	-6.07	-8.15	-6.54	-8.89	-10.37	-9.83	-9.60	14.98	7.73	6.40	7.69	62.04	7.63	4.67	4.674
FCF/OCF	0.91	0.88	0.75	0.44	0.12	0.34	0.57	0.74	0.80	0.75	0.78	0.76	0.70	0.74	0.71	0.69	0.73	0.66	0.72	0.77	0.774
FCF/Net Income	snapshot only																				3.618
OCF/EBITDA	snapshot only																				1.735
CapEx/Revenue	2.2%	2.6%	3.3%	3.4%	3.7%	4.0%	3.6%	3.9%	3.9%	3.9%	4.3%	4.5%	4.8%	4.3%	4.2%	3.9%	3.5%	3.6%	3.6%	3.3%	3.31%
CapEx/Depreciation	snapshot only																				1.002
Accruals Ratio	-0.09	-0.08	-0.04	-0.01	-0.00	-0.03	-0.06	-0.10	-0.12	-0.09	-0.11	-0.10	-0.08	-0.08	-0.06	-0.06	-0.06	-0.06	-0.07	-0.07	-0.069
Sloan Accruals	snapshot only																				-0.002
Cash Flow Adequacy	snapshot only																				4.426
Earnings Quality Score	snapshot only																				0.750

Dividends & Buybacks

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Dividend Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Dividend/Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—	—	—	—	—	—	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
FCF Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Total Payout Ratio	5.8%	7.9%	81.1%	96.3%	1.2%	9.6%	—	—	—	—	—	—	—	0.0%	0.0%	67.8%	3.9%	37.8%	3.8%	1.6%	1.59%
Div. Increase Streak	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Chowder Number	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Buyback Yield	0.1%	0.1%	0.9%	1.1%	1.5%	2.4%	0.1%	0.1%	0.1%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	1.1%	5.5%	3.8%	5.1%	3.3%	3.25%
Net Buyback Yield	-0.7%	-0.5%	0.4%	0.7%	0.9%	1.5%	-1.2%	-0.9%	-1.0%	-1.4%	-1.4%	-1.3%	-0.7%	-1.9%	-2.4%	-1.7%	2.6%	3.0%	4.0%	2.8%	2.81%
Total Shareholder Return	-0.7%	-0.5%	0.4%	0.7%	0.9%	1.5%	-1.2%	-0.9%	-1.0%	-1.4%	-1.4%	-1.3%	-0.7%	-1.9%	-2.4%	-1.7%	2.6%	3.0%	4.0%	2.8%	2.81%

DuPont Factors

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Tax Burden (NI/EBT)	1.10	1.18	1.24	1.32	1.20	-2.30	0.61	0.85	0.93	1.01	1.26	1.00	1.07	0.49	0.63	0.64	0.58	0.18	0.54	0.64	0.639
Interest Burden (EBT/EBIT)	0.74	0.74	0.77	0.78	0.84	1.06	0.94	0.77	0.74	0.58	0.59	0.63	0.69	1.07	1.17	1.00	0.99	0.83	0.90	0.95	0.954
EBIT Margin	0.09	0.08	0.06	0.05	0.04	-0.00	-0.02	-0.03	-0.04	-0.03	-0.03	-0.03	-0.02	0.02	0.03	0.03	0.03	0.01	0.03	0.05	0.051
Asset Turnover	0.57	0.57	0.60	0.61	0.62	0.60	0.58	0.57	0.54	0.52	0.49	0.48	0.47	0.51	0.51	0.52	0.55	0.58	0.59	0.60	0.602
Equity Multiplier	1.86	1.88	1.92	1.91	1.88	1.91	1.97	1.92	1.89	1.91	1.95	1.90	1.87	1.79	1.81	1.80	1.73	1.65	1.65	1.62	1.622

Per Share

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
EPS (Diluted TTM)	$1.66	$1.56	$1.50	$1.31	$1.05	$0.13	$-0.39	$-0.51	$-0.75	$-0.45	$-0.46	$-0.45	$-0.38	$0.27	$0.45	$0.49	$0.43	$0.05	$0.44	$0.85	$0.85
Book Value/Share	$22.99	$23.00	$22.43	$23.62	$24.78	$25.30	$25.45	$25.59	$26.04	$26.13	$25.99	$26.13	$26.52	$26.88	$26.98	$27.06	$26.17	$27.40	$27.35	$28.00	$28.41
Tangible Book/Share	$3.67	$0.67	$-0.61	$0.19	$1.48	$1.62	$2.14	$2.82	$3.61	$3.85	$4.04	$4.50	$6.47	$5.66	$6.03	$6.24	$5.47	$7.20	$6.55	$7.41	$7.41
Revenue/Share	$22.14	$22.71	$25.02	$27.19	$28.58	$29.01	$28.24	$27.17	$26.01	$25.21	$24.11	$23.47	$22.92	$24.05	$24.37	$24.62	$25.24	$26.35	$26.66	$27.03	$27.42
FCF/Share	$4.66	$4.07	$2.49	$0.74	$0.14	$0.59	$1.34	$3.10	$3.92	$3.00	$3.75	$3.37	$2.55	$3.01	$2.50	$2.19	$2.39	$1.88	$2.43	$3.07	$3.11
OCF/Share	$5.14	$4.65	$3.31	$1.67	$1.21	$1.74	$2.37	$4.16	$4.93	$3.98	$4.77	$4.43	$3.66	$4.06	$3.51	$3.16	$3.28	$2.83	$3.39	$3.96	$4.02
Cash/Share	$10.18	$7.22	$5.76	$5.56	$6.09	$7.65	$7.83	$9.03	$10.06	$10.29	$11.47	$12.37	$12.54	$8.25	$8.57	$8.82	$4.15	$4.37	$5.52	$6.66	$6.75
EBITDA/Share	$3.72	$3.50	$3.42	$3.30	$3.17	$2.17	$1.53	$1.37	$1.02	$1.34	$1.44	$1.31	$1.45	$2.46	$2.52	$2.60	$2.52	$2.14	$2.64	$2.28	$2.28
Debt/Share	$11.09	$10.85	$12.80	$13.41	$13.49	$13.80	$13.70	$13.52	$13.43	$13.50	$13.46	$13.37	$13.23	$8.27	$8.28	$8.23	$4.43	$4.55	$4.40	$4.34	$4.34
Net Debt/Share	$0.91	$3.64	$7.04	$7.85	$7.41	$6.15	$5.87	$4.49	$3.38	$3.21	$1.99	$1.00	$0.69	$0.02	$-0.29	$-0.58	$0.29	$0.17	$-1.12	$-2.32	$-2.32

Academic Models

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	2.822
Altman Z-Prime	snapshot only																				4.690
Piotroski F-Score	7	6	5	5	5	6	6	5	5	4	4	5	4	6	7	7	7	7	8	9	9
Beneish M-Score	-2.50	-2.44	-2.19	-1.97	-1.98	-2.35	-2.61	-3.01	-3.25	-3.00	-3.12	-3.00	-2.93	-2.90	-2.80	-2.82	-2.80	-2.85	-2.82	-2.89	-2.887
Ohlson O-Score	snapshot only																				-8.716
ROIC (Greenblatt)	snapshot only																				14.85%
Net-Net WC	snapshot only																				$0.61
EVA	snapshot only																				$-80769338.44

Credit

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Credit Rating	snapshot only																				AA-
Credit Score	90.19	85.33	76.49	81.69	70.05	42.11	41.84	49.43	55.38	56.60	37.53	37.07	28.20	64.83	66.45	66.72	77.07	65.65	74.46	83.11	83.106
Credit Grade	snapshot only																				4
Credit Trend	snapshot only																				16.387
Implied Spread (bps)	snapshot only																				100.000
Industry Credit Rank	snapshot only																				83
Sector Credit Rank	snapshot only																				80

OMCL NASDAQ

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet